600566 Stock Overview
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China.
Hubei Jumpcan Pharmaceutical Co., Ltd. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||CN¥31.97|
|52 Week High||CN¥35.25|
|52 Week Low||CN¥17.80|
|1 Month Change||4.78%|
|3 Month Change||37.62%|
|1 Year Change||76.24%|
|3 Year Change||43.24%|
|5 Year Change||-13.48%|
|Change since IPO||61.38%|
Recent News & Updates
|600566||CN Pharmaceuticals||CN Market|
Return vs Industry: 600566 exceeded the CN Pharmaceuticals industry which returned -13.5% over the past year.
Return vs Market: 600566 exceeded the CN Market which returned -19.4% over the past year.
|600566 Average Weekly Movement||7.6%|
|Pharmaceuticals Industry Average Movement||6.5%|
|Market Average Movement||5.9%|
|10% most volatile stocks in CN Market||9.1%|
|10% least volatile stocks in CN Market||3.8%|
Stable Share Price: 600566 is more volatile than 75% of CN stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: 600566's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develops Chinese and western medicines in the areas of detoxification, digestive system, respiratory system, nervous system, anti-infection, cardiovascular, narcotic analgesic, nutrition, musculoskeletal, and hemostasis.
Hubei Jumpcan Pharmaceutical Co., Ltd. Fundamentals Summary
|600566 fundamental statistics|
Is 600566 overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|600566 income statement (TTM)|
|Cost of Revenue||CN¥1.37b|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||2.21|
|Net Profit Margin||25.13%|
How did 600566 perform over the long term?See historical performance and comparison